FDA Calls On Drugmaker To Pull A Powerful Opioid Off The Market

The U.S. Food and Drug Administration (FDA) is calling on Endo Pharmaceuticals to stop selling a specific opioid painkiller, Opana ER, due to the "public health consequences of abuse." This is the first time the FDA has acted to remove an opioid from the market, citing the frequent misuse of the drug and associated outbreaks of HIV, hepatitis C, and another serious but less well-known blood disorder called thrombotic microangiopathy. Endo Pharmaceuticals released a statement highlighting their efforts to prevent abuse of the drug and stating that they are reviewing the FDA's request.
Source: News stories via the Rural Assistance Center - Category: Rural Health Source Type: news